KMDA
Price
$7.72
Change
-$0.06 (-0.77%)
Updated
Jul 25 closing price
Capitalization
306.49M
18 days until earnings call
OGI
Price
$1.53
Change
+$0.02 (+1.32%)
Updated
Jul 25 closing price
Capitalization
200.85M
Interact to see
Advertisement

KMDA vs OGI

Header iconKMDA vs OGI Comparison
Open Charts KMDA vs OGIBanner chart's image
Kamada
Price$7.72
Change-$0.06 (-0.77%)
Volume$18.11K
Capitalization306.49M
Organigram Global
Price$1.53
Change+$0.02 (+1.32%)
Volume$749.42K
Capitalization200.85M
KMDA vs OGI Comparison Chart in %
Loading...
KMDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OGI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KMDA vs. OGI commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KMDA is a Hold and OGI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (KMDA: $7.72 vs. OGI: $1.53)
Brand notoriety: KMDA and OGI are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: KMDA: 26% vs. OGI: 128%
Market capitalization -- KMDA: $306.49M vs. OGI: $200.85M
KMDA [@Pharmaceuticals: Other] is valued at $306.49M. OGI’s [@Pharmaceuticals: Other] market capitalization is $200.85M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KMDA’s FA Score shows that 0 FA rating(s) are green whileOGI’s FA Score has 1 green FA rating(s).

  • KMDA’s FA Score: 0 green, 5 red.
  • OGI’s FA Score: 1 green, 4 red.
According to our system of comparison, OGI is a better buy in the long-term than KMDA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KMDA’s TA Score shows that 4 TA indicator(s) are bullish while OGI’s TA Score has 4 bullish TA indicator(s).

  • KMDA’s TA Score: 4 bullish, 4 bearish.
  • OGI’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, OGI is a better buy in the short-term than KMDA.

Price Growth

KMDA (@Pharmaceuticals: Other) experienced а +3.62% price change this week, while OGI (@Pharmaceuticals: Other) price change was +5.52% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.55%. For the same industry, the average monthly price growth was +12.00%, and the average quarterly price growth was +75.03%.

Reported Earning Dates

KMDA is expected to report earnings on Nov 12, 2025.

OGI is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+3.55% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KMDA($306M) has a higher market cap than OGI($201M). KMDA YTD gains are higher at: 30.397 vs. OGI (-4.969). KMDA has higher annual earnings (EBITDA): 22.4M vs. OGI (-195.74M). KMDA has more cash in the bank: 55.6M vs. OGI (42.3M). OGI has less debt than KMDA: OGI (136K) vs KMDA (8.82M). OGI has higher revenues than KMDA: OGI (161M) vs KMDA (143M).
KMDAOGIKMDA / OGI
Capitalization306M201M152%
EBITDA22.4M-195.74M-11%
Gain YTD30.397-4.969-612%
P/E Ratio37.43N/A-
Revenue143M161M89%
Total Cash55.6M42.3M131%
Total Debt8.82M136K6,487%
FUNDAMENTALS RATINGS
KMDA vs OGI: Fundamental Ratings
KMDA
OGI
OUTLOOK RATING
1..100
7119
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
50
Fair valued
PROFIT vs RISK RATING
1..100
95100
SMR RATING
1..100
8083
PRICE GROWTH RATING
1..100
4847
P/E GROWTH RATING
1..100
4531
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OGI's Valuation (50) in the null industry is in the same range as KMDA (71) in the Biotechnology industry. This means that OGI’s stock grew similarly to KMDA’s over the last 12 months.

KMDA's Profit vs Risk Rating (95) in the Biotechnology industry is in the same range as OGI (100) in the null industry. This means that KMDA’s stock grew similarly to OGI’s over the last 12 months.

KMDA's SMR Rating (80) in the Biotechnology industry is in the same range as OGI (83) in the null industry. This means that KMDA’s stock grew similarly to OGI’s over the last 12 months.

OGI's Price Growth Rating (47) in the null industry is in the same range as KMDA (48) in the Biotechnology industry. This means that OGI’s stock grew similarly to KMDA’s over the last 12 months.

OGI's P/E Growth Rating (31) in the null industry is in the same range as KMDA (45) in the Biotechnology industry. This means that OGI’s stock grew similarly to KMDA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KMDAOGI
RSI
ODDS (%)
Bearish Trend 1 day ago
83%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
65%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
73%
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
Bearish Trend 1 day ago
62%
Bullish Trend 1 day ago
77%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
64%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
67%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 6 days ago
66%
Bullish Trend 5 days ago
84%
Declines
ODDS (%)
Bearish Trend 1 day ago
66%
N/A
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
56%
Bullish Trend 1 day ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
KMDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OGI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MQBKY140.770.54
+0.39%
Macquarie Group, Ltd.
CGHOF1.00N/A
N/A
China Gas Holdings Ltd.
LEKOF0.01N/A
N/A
Lekoil Ltd
KNFSF1.32N/A
N/A
Kiatnakin Phatra Bank Public Company Ltd.
ONVVF0.16N/A
N/A
Oneview Healthcare PLC